Lukas Speiser
Founder and CEO @ Amorana
Zürich, Switzerland
Lukas Speiser is a seed investor at Amorana in Zürich focused on Health Care and SaaS. Lukas Speiser is the founder and CEO of Amorana.ch
- Total investments:
- 8
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Lukas Speiser invests in
Stages Lukas Speiser invests in
Countries Lukas Speiser invests in
Round sizes
Round size
- Seed
- $161k–$3M
Investment Focus
Industry
- Health Care 2 (25%)
- SaaS 1 (13%)
- Retail 1 (13%)
- FinTech 1 (13%)
- Medical 1 (13%)
Stage
- Seed 4 (50%)
- Funding Round 3 (38%)
- Pre-Seed 1 (13%)
Country
- Switzerland 6 (75%)
- Germany 1 (13%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
NextBusiness
|
NextBusiness makes tools for founders in Switzerland. We build the AI-first business software infinity.swiss. | $3M / Seed / Jun 30, 2026 | |
Dunatura
|
Dunatura engages in the manufacture and supply of vitamins and micronutrients. | Seed / Mar 23, 2022 | |
Cleveron
|
Cleveron is an innovative Swiss start up company that has developed an intelligent system for radiator heating systems. With Cleveron, the room temperature in each individual room of a building can be individually and optimally controlled. This can save costs and energy. Simple Home's technology makes an active contribution to reducing CO 2emissions.They have the vision to make part of the big, public buildings in Switzerland and Europe, such as school buildings and administrative buildings, more environmentally friendly. To make this happen, they want to convince cities and communities to convert their buildings to Cleveron technology as quickly as possible. Because with the conversion they are now making a concrete contribution to the rescue of the climate. | $513.9K / Nov 24, 2021 | |
Findependent
|
Findependent goal is to enable you to make more of your savings with findependent and thus to be able to live more financially independently and self-determined - financially independent or findependent for short. | $160.6K / Seed / Nov 24, 2021 | |
feey
|
feey is a houseplant shop. They offer plants that include entry-level plants, baby plants, animal-friendly plants, large plants, home office plants, hanging plants, aglaonema, alocasia, calathea, hoya, monstera, and philodendron. | $1.2M / Nov 10, 2021 | |
|
feey
|
feey is a houseplant shop. They offer plants that include entry-level plants, baby plants, animal-friendly plants, large plants, home office plants, hanging plants, aglaonema, alocasia, calathea, hoya, monstera, and philodendron. | $1.3M / Pre-Seed / Nov 10, 2021 | |
Sleepiz
|
Sleepiz is a Zürich based startup with the aim to enable the medical community to take healthcare into the home environment. Sleepiz provides an easy and comfortable to use solution with a device that is simply placed on the bedside table. The device operates in a non-contact fashion and measures movements originating from heart contractions andbreathing patterns as well as body motions with medical grade accuracy.By making use of wireless millimeter wave technology, sensor fusion and artificial intelligence Sleepiz will in the future not only able to diagnose sleep disorders, but also to perform long-term monitoring. Thereby, the progression of chronic diseases can be monitored to allow faster intervention and better treatment. | Nov 04, 2021 | |
Testmate Health
|
Testmate Health is a medtech startup and award-winning spin-off of University of Geneva (Switzerland). We have developed a smartphone compatible platform test kit that diagnoses any disease with an identifiable DNA or RNA sequence - without the need for a lab, providing results directly at home in minutes. Based on this platform, our firstsolution is the first rapid urine self-test for the four most common sexually transmitted diseases (STD). One million new STDs are diagnosed a day, and yet the best improvements to date still need a lab, with results taking up to 7 days to be ready. Our easy to use all-in-one-kit provides results in minutes, anywhere, at any time, and the result is scannable by a smartphone to enable people to immediately gain access to treatment – if needed. Further test-kits with other diseases are in the pipeline to empower users to skip the waiting room, and take charge of their health from home. | $1.9M / Seed / Oct 21, 2021 |
Co-Investors
About Amorana
Amorana is a pure online shop with high-quality products from the lifestyle erotic area. Here you will find a large selection of top brands from around the world. They value a wide range of popular products and always try to respond to current trends. Amorana is a Swiss company and stands for absolute discretion and highest customer satisfaction.
Amorana Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Lukas Speiser
Founder and CEO
|
|||
4 more contacts available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does Lukas Speiser invest in?
Lukas Speiser invests primarily in Health Care, SaaS and Retail startups, most often at Seed and Funding Round stage. Most of the 8 investments tracked by Shizune back companies in Switzerland. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Lukas Speiser's check size?
Lukas Speiser typically joins rounds of $161k–$3M at Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Lukas Speiser participates in.
When did Lukas Speiser last invest?
The most recent investment recorded for Lukas Speiser closed in Jun 2026. Shizune tracks 8 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
